EXAS vs WVE · rev $2.76B vs rev $40.5M
EXACT Sciences Corporation (EXAS) versus Wave Life Sciences Ltd (WVE) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Wave Life Sciences Ltd (WVE) is a biotechnology company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported WVE revenue for 2026-06-30 was $40.5M. Net income was -$95.4M. Revenue was up 5.9% from 2026-03-31 to 2026-06-30. WVE currently screens at market cap $1.13B.
EXAS currently screens at market cap $20.03B. WVE currently screens at market cap $1.13B.
Not investment advice. Open the EXAS and WVE stock pages for the full models.
Not investment advice.